journal article·2025-04

Influence of pyrazinamide loaded zeolite imidazole framework (ZIF-8) nanoparticles and effective anticancer effect in breast cancer cells

Karthick Arumugam, Azar Zochedh, Kaliraj Chandran, Sureba Sukumaran, Karthikeyan Palaniyandi, Asath Bahadur Sultan, Thandavarayan Kathiresan

Journal of Nanoparticle Research· Volume 27· Issue 4
Publisher page

Abstract

No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.

Source: Not provided · Quality: missing

Research context

OpenAlex topics: Synthesis and biological activity · Synthesis of Tetrazole Derivatives · Computational Drug Discovery Methods

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (40)

Show source-provided references
1. Waks AG, Winer EP (2019) Breast cancer treatment: a review. Jama 321(3):288–30010.1001/jama.2018.19323 ↗
2. Comşa Ş, Cimpean AM, Raica M (2015) The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res 35(6):3147–3154
3. De Jong WH, Borm PJ (2008) Drug delivery and nanoparticles: applications and hazards. Int J Nanomed 3(2):133–14910.2147/IJN.S596 ↗
4. Liu G, Yang L, Chen G, Xu F, Yang F, Yu H, ... Li B (2021) A review on drug delivery system for tumor therapy. Front Pharmacol, 12, 73544610.3389/fphar.2021.735446 ↗
5. Huxford RC, Della Rocca J, Lin W (2010) Metal–organic frameworks as potential drug carriers. Curr Opin Chem Biol 14(2):262–26810.1016/j.cbpa.2009.12.012 ↗
6. Zhao H, Gong L, Wu H, Liu C, Liu, Y, Xiao C, ... Huang W (2023) Development of novel paclitaxel-loaded ZIF-8 metal-organic framework nanoparticles modified with peptide dimers and an evaluation of its inhibitory effect against prostate cancer cells. Pharmaceutics, 15(7), 187410.3390/pharmaceutics15071874 ↗
7. Fang M, Wu C, Yang Z, Wang T, Xia Y, Li J (2015) ZIF-8/PDMS mixed matrix membranes for propane/nitrogen mixture separation: experimental result and permeation model validation. J Membr Sci 474:103–11310.1016/j.memsci.2014.09.040 ↗
8. Proenza YG, Longo RL (2019) Simulation of the adsorption and release of large drugs by ZIF-8. J Chem Inf Model 60(2):644–65210.1021/acs.jcim.9b00893 ↗
9. Rodrigues FA, Bomfim IDS, Cavalcanti BC, do OPessoa C, Pinheiro AC, Lima CH, de Souza VNM (2014) Biological evaluation of pyrazinamide derivatives as an anticancer class. Eur Chem Bull 3:358–61
10. Kouranov A, Xie L, de la Cruz J, Chen L, Westbrook J, Bourne PE, Berman HM (2006) The RCSB PDB information portal for structural genomics. Nucleic Acids Res 34(suppl_1):D302–D30510.1093/nar/gkj120 ↗
11. Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, ... Bryant SH (2016) PubChem substance and compound databases. Nucleic acids research, 44(D1), D1202-D121310.1093/nar/gkv951 ↗
12. Jejurikar BL, Rohane SH (2021) Drug designing in discovery studio. pp 135–138
13. Dallakyan S, Olson AJ (2015) Small-molecule library screening by docking with PyRx. Chemical biology: methods and protocols. Springer, New York, pp 243–25010.1007/978-1-4939-2269-7_19 ↗
14. Zhang Y, Huo M, Zhou J, Zou A, Li W, Yao C, Xie S (2010) DDSolver: an add-in program for modeling and comparison of drug dissolution profiles. AAPS J 12:263–27110.1208/s12248-010-9185-1 ↗
15. Zochedh A, Chandran K, Arumugam K, Priya M, Anbazhagan M, Sultan AB, ... Kathiresan T (2024) Encapsulating 2-aminopyridine with zeolite imidazole framework nanoparticles for induction of cell death via pH-responsive delivery in hepatocellular carcinoma (HepG2) cells. Polycyclic Aromatic Compounds, 1–1910.1080/10406638.2024.2344764 ↗
16. Zochedh A, Shunmuganarayanan A, Ansar S, Kumar YA, Sultan AB (2025) Integrating simulated and experimental studies on novel single crystal bis (guanidininium) n-carboxylatephenylalanine towards enhanced antitumor effect. J Mol Struct 1321:14015510.1016/j.molstruc.2024.140155 ↗
17. Awasthi KK, Awasthi A, Verma R, Kumar N, Roy P, Awasthi K, John PJ (2015) Cytotoxicity, genotoxicity and alteration of cellular antioxidant enzymes in silver nanoparticles exposed CHO cells. RSC Adv 5(44):34927–3493510.1039/C4RA15944F ↗
18. Kalimuthu AK, Pandian SRK, Pavadai P, Panneerselvam T, Kabilan SJ, Sankaranarayanan M, ... Kunjiappan S (2023) Drug delivery applications of exopolysaccharides from endophytic bacteria Pseudomonas otitidis from Tribulus terrestris L. J Polym Environ 31(8), 3632–364910.1007/s10924-023-02848-4 ↗
19. Vogt A (2010) Advances in two-dimensional cell migration assay technologies. Eur Pharm Rev 5:26–29
20. Sukumaran S, Zochedh A, Chandran K, Sultan AB, Kathiresan T (2024) Combinatory effect of gemcitabine and 5-fluorouracil investigated through chemoinformatics and molecular dynamics simulation against breast cancer. Int J Quantum Chem 124(20):e2749810.1002/qua.27498 ↗
21. Priya M, Zochedh A, Chandran K, Arumugam K, Banu S, Chakaravarthy C, Sultan AB (2022) Computer-aided analysis of biochanin-a as a potential breast cancer drug based on dft, molecular docking, and pharmacokinetic studies. Lett Appl NanoBioSci 12(4):165
22. Arumugam K, Chandran K, Zochedh A, Ansar S, Sultan AB, Kumar YA, Kathiresan T (2024) Pharmacoinformatics and quantum chemicals-based analysis of aromatic molecule decanal as a potent drug against breast cancer. Int J Quantum Chem 124(15):e2745110.1002/qua.27451 ↗
23. Priya M, Zochedh A, Mohan YS, Chandran K, Arumugam K, Sultan AB (2024) Network analysis and molecular modeling studies of pinocembrin a bioactive phytochemical of Dodonaea viscosa against Parkinson’s disease. Silico Pharmacol 12(2):1–1510.1007/s40203-024-00268-3 ↗
24. Zochedh A, Chandran K, Priya M, Sultan AB, Kathiresan T (2024) DFT simulation of berberine chloride with spectroscopic characterization–biological activity and molecular docking against breast cancer. Polycyclic Aromat Compd 44(3):1556–158010.1080/10406638.2023.2201457 ↗
25. Chandran K, Zochedh A, Sultan AB, Kathiresan T (2023) Observations into quantum simulation, spectroscopy, electronic properties, pharmacokinetics and molecular docking analysis of lawsone against breast cancer. J Mol Struct 1293:13628010.1016/j.molstruc.2023.136280 ↗
26. Zochedh A, Shunmuganarayanan A, Sultan AB (2024) Insight with crystallization, quantum computation, Hirshfeld, ELF/LOL and molecular docking of syringic acid nicotinamide cocrystal as potent Mycobacterium tuberculosis inhibitor. J Comput Biophys Chem 23(1):1–2410.1142/S2737416523500461 ↗
27. Ahmadian-Yazdi MR, Gholampour N, Eslamian M (2020) Interface engineering by employing zeolitic imidazolate framework-8 (ZIF-8) as the only scaffold in the architecture of perovskite solar cells. ACS Appl Energy Mater 3(4):3134–314310.1021/acsaem.9b02115 ↗
28. Siva V, Murugan A, Shameem A, Thangarasu S, Kannan S, Bahadur SA (2023) In situ encapsulation of V 2 O 5@ ZIF-8 nanocomposites as electrode materials for high-performance supercapacitors with long term cycling stability. J Mater Chem C 11(8):3070–308510.1039/D2TC03996F ↗
29. Priya M, Zochedh A, Palaniyandi K, Shunmuganarayanan A, Sultan AB (2024) Combinatorial effect of syringic acid-pyrazinamide adduct against luminal type breast cancer investigated through DFT, drug-likeness, and molecular docking simulation. Polycyclic Aromat Compd 44(3):2090–211810.1080/10406638.2023.2212105 ↗
30. Zhang Y, Jia Y, Li M, Hou LA (2018) Influence of the 2-methylimidazole/zinc nitrate hexahydrate molar ratio on the synthesis of zeolitic imidazolate framework-8 crystals at room temperature. Sci Rep 8(1):959710.1038/s41598-018-28015-7 ↗
31. Siva V, Murugan A, Shameem A, Thangarasu S, Bahadur SA (2022) A simple synthesis method of zeolitic imidazolate framework-8 (ZIF-8) nanocrystals as superior electrode material for energy storage systems. J Inorg Organomet Polym Mater 32(12):4707–471410.1007/s10904-022-02475-x ↗
32. Karthikeyan P, Murugan A, Siva V, Shameem A, Chinnaiah K, Thangarasu S, Bahadur SA (2024) Optimization of NiFe2O4 by different facile synthetic approaches and investigations on structural and electrochemical properties. Inorg Chem Commun 160:11193110.1016/j.inoche.2023.111931 ↗
33. Nasef AM, Gardouh AR, Ghorab MM (2015) Polymeric nanoparticles: influence of polymer, surfactant and composition of manufacturing vehicle on particle size. World J Pharm Sci 3:2308–2322
34. Naveenkumar S, Alagumanikumaran N, Kaviyarasu K, Muthukumaran A (2024) Influence of encapsulated sodium alginates and pectin on selenium nanoparticles and efficient cardioprotective effect in C2C12 cell line. J Nanopart Res 26(3):5210.1007/s11051-024-05956-x ↗
35. Viswanathan TM, Chitradevi K, Zochedh A, Vijayabhaskar R, Sukumaran S, Kunjiappan S, ... Kathiresan T (2022).Guanidine–curcumin complex-loaded amine-functionalised hollow mesoporous silica nanoparticles for breast cancer therapy. Cancers 14(14):349010.3390/cancers14143490 ↗
36. Mohan Viswanathan T, Krishnakumar V, Senthilkumar D, Chitradevi K, Vijayabhaskar R, Rajesh Kannan V, ... Kathiresan T (2022) Combinatorial delivery of gallium (III) nitrate and curcumin complex-loaded hollow mesoporous silica nanoparticles for breast cancer treatment. Nanomaterials 12(9):147210.3390/nano12091472 ↗
37. Chandran K, Zochedh A, Sultan AB, Kathiresan T (2024) Investigation on 5-isopropyl-2-methylphenol via quantum chemicals, pharmacokinetics, molecular docking and cytotoxicity evaluation against breast cancer. J Comput Biophys Chem 23(1):93–11610.1142/S2737416523500539 ↗
38. Zochedh A, Chandran K, Arumugam K, Al-Asbahi BA, Sultan AB, Kumar YA, Priya M, Kathiresan T (2024) Functionalization of ZIF-8 nanoparticles for efficient delivery of 4-aminoantipyrine and apoptosis induction in breast cancer cells. Chemistry Africa. https://doi.org/10.1007/s42250-024-01133-810.1007/s42250-024-01133-8 ↗
39. Guo HL, Hassan HM, Ding PP, Wang SJ, Chen X, Wang T, ... Jiang ZZ (2017) Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK-eIF2α-ATF4-CHOP pathway. Toxicology 378, 65–7510.1016/j.tox.2017.01.002 ↗
40. Zochedh A, Reni K, Shunmuganarayanan A, Ansar S, Kumar YA, Sultan AB (2025) Synthesis, characterization, in silico and in vitro assessment of 2-aminopyridine nicotinamide cocrystal as a new agent for breast cancer therapy. J Mol Struct 1322:14031510.1016/j.molstruc.2024.140315 ↗